Bright Uro
Bright Uro is a medical technology company that has developed the Glean Urodynamics System, the first FDA-cleared wireless, catheter-free platform for diagnosing lower urinary tract symptoms in urology practices and hospital systems.
- Company typePrivate
- Founded2021
- HeadquartersAliso Viejo, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bright Uro does
Bright Uro is a medical technology company that has developed the Glean Urodynamics System, the first FDA-cleared wireless, catheter-free platform for diagnosing lower urinary tract symptoms (LUTS). The system uses proprietary sensor technology to capture patients' natural filling and voiding cycles without the forced bladder filling/emptying required by conventional catheter-based urodynamics. In May 2026, Bright Uro received FDA 510(k) clearance for its Glean Abdominal Sensor, extending the platform to support wireless, catheter-free multi-channel urodynamic studies. The company also operates the Glean Patient Registry, launched April 2026, designed to collect de-identified real-world urodynamic data as a foundation for future AI/ML algorithm development.
The company generates revenue through hardware sales of the Glean system to clinical urology practices and hospital systems, employing an enterprise field sales motion with demo-based evaluation and direct sales outreach. Its target buyers are urologists, urology departments, and integrated health systems performing diagnostic testing for bladder dysfunction. The clinical value proposition addresses pain points including patient discomfort and dignity loss during catheter-based testing, scheduling delays of 4-6 weeks, geographic concentration of urodynamics capacity, and diagnostic data that may not reflect real-life symptoms. Peer-reviewed publications in the Journal of Endourology support claims of equal or better diagnostic performance and patient preference versus conventional urodynamics.
Founded in 2021 and headquartered in Irvine, California, Bright Uro is venture-backed, having raised a $32 million oversubscribed Series A in October 2024 led by Laborie Medical Technologies with UC Investments, Freepoint Capital, and Laurelin Investors. An additional strategic investment from Laborie Medical Technologies in November 2023 anchors a urology-diagnostics-aligned investor base, and supplemental funding from NIH (2022) and the Congressionally Directed Medical Research Programs (2025) provides non-dilutive validation. The company operates with 11-50 employees and is positioning for commercial scale-up against an addressable market estimated at approximately 80 million Americans with LUTS and a global urodynamic equipment market projected to grow from $478 million in 2025 to $808 million by 2034.
Bright Uro firmographics
Firmographics- Name
- Bright Uro
- Legal name
- Bright Uro, Inc.
- Website
- https://brighturo.com/
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bright Uro is a medical technology company that has developed the Glean Urodynamics System, the first FDA-cleared wireless, catheter-free platform for diagnosing lower urinary tract symptoms in urology practices and hospital systems.
- Ownership category
- akta.pro rank
Bright Uro industry classification
Industry- Product category
- Urodynamics Diagnostic Devices
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ)
- akta.pro secondary industry
- Neurourology & Voiding Dysfunction (HLAKAOAI)
Keywords
Where Bright Uro is headquartered
LocationHeadquarters
- HQ city
- Aliso Viejo
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Bright Uro business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Revenue model
- Glean Urodynamics System (Hardware + Testing): Bright Uro generates revenue from the sale and deployment of the Glean Urodynamics System, which includes proprietary hardware sensors and associated diagnostic services. The system is used in clinical settings for diagnosing lower urinary tract symptoms.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Bright Uro product offering
Product offeringCore offering
Bright Uro develops and manufactures the Glean Urodynamic System, a wireless, catheter-free urodynamics diagnostic platform that captures a patient's natural filling and voiding cycles to evaluate lower urinary tract symptoms. The offering is extended by the FDA 510(k) cleared Glean Abdominal Sensor add-on and supported by the Glean Registry / Urodynamic Intelligence data platform for clinicians managing patients with bladder dysfunction.
Product overview
Bright Uro offers the Glean Urodynamic System, which is a wireless, catheter-free urodynamics diagnostic system. The product portfolio consists of the Glean Urodynamics System as the core product and the Glean Abdominal Sensor as an FDA 510(k) cleared add-on module. The system is designed to diagnose lower urinary tract symptoms using a novel catheter-free approach.
Differentiator
Problem solved
Functional benefit
Brands
- Glean Urodynamic System: First and only wireless, catheter-free urodynamics system for diagnosing lower urinary tract symptoms. The system captures natural filling and voiding cycles for more accurate diagnostic data.
Products and services
- Glean Urodynamic System Wireless, catheter-free urodynamics diagnostic system that captures a patient's natural filling and voiding cycles for the diagnostic evaluation of lower urinary tract symptoms; intended for urology practices, hospital outpatient urology departments, and specialty urogynecology / pelvic floor clinics.
- Glean Abdominal Sensor FDA 510(k) cleared add-on sensor for the Glean Urodynamic System that non-invasively captures abdominal pressure as part of a multi-channel urodynamic study, enabling catheter-free urodynamics workflows in clinical urology settings.
Quantifiable outcome
- Equal or better diagnostic performance compared to traditional catheters (Hamson, et al, J Endourology, 2026)
- +2 more outcomes
Companies that use Bright Uro
Customer profileSegments2 records
Ideal customer profiles1 record
Bright Uro technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Bright Uro partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights4 records
Bright Uro competitors and assessment
Company assessmentDirect peers
- Laborie Medical Technologies: Laborie is the established leader in urodynamics equipment and consumables, offering conventional catheter-based urodynamic systems. It is a direct competitor in the same product category and clinical workflow as Bright Uro's Glean system, while also serving as a strategic investor in Bright Uro.
- SRS Medical: SRS Medical specializes in urodynamic systems and pelvic floor diagnostic equipment, including urodynamics catheters and related consumables. It is one of the few direct urodynamics equipment peers competing for the same clinical workflow.
Broad incumbents
- CooperSurgical: CooperSurgical offers urodynamic evaluation systems and related women's health/pelvic floor diagnostics through its portfolio. It serves overlapping urology and urogynecology customers and competes with Bright Uro in diagnostic urodynamic workflows.
- Verathon: Verathon manufactures urology and bladder diagnostics including bladder volume scanners. While it does not currently offer a catheter-free urodynamic study system, it serves overlapping urology customers with complementary bladder function diagnostics.
- Medtronic: Medtronic operates in urology through sacral neuromodulation (InterStim) and other bladder dysfunction therapies. While not a direct urodynamics equipment peer, it addresses the same patient population (lower urinary tract dysfunction) downstream of Bright Uro's diagnostic use case.
- Boston Scientific: Boston Scientific has a broad urology portfolio spanning stone management, BPH treatment, and pelvic health. It serves the same urology customer base as Bright Uro and represents a potential strategic acquirer or competitive entrant in advanced bladder diagnostics.
- Coloplast: Coloplast is a major continence care and urology company with catheters, ostomy products, and urological devices. It overlaps with Bright Uro's urology customer base and competes indirectly in the bladder dysfunction treatment pathway.
- Hollister Incorporated: Hollister manufactures continence care products including urinary catheters and drainage systems. As the incumbent in catheter-based urinary care that Bright Uro is disrupting, it is a relevant comparable for distribution, clinician relationships, and competitive response.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Bright Uro social profiles
Digital presenceBright Uro financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bright Uro leadership team
Management profileNumber of profiles
Profiles1 record
Bright Uro funding detail
Funding detailFunding overview
Funding rounds7 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bright Uro M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bright Uro
What does Bright Uro do?
Bright Uro develops and manufactures the Glean Urodynamic System, a wireless, catheter-free urodynamics diagnostic platform that captures a patient's natural filling and voiding cycles to evaluate lower urinary tract symptoms. The offering is extended by the FDA 510(k) cleared Glean Abdominal Sensor add-on and supported by the Glean Registry / Urodynamic Intelligence data platform for clinicians managing patients with bladder dysfunction.
Is Bright Uro a public or private company?
Bright Uro is a private company. It is classified as venture growth investor backed and is currently operating.
When was Bright Uro founded?
Bright Uro was founded in 2021. It employs 11 to 50 people.
Where is Bright Uro based?
Bright Uro is headquartered in Aliso Viejo, United States, in the North America region.
How does Bright Uro make money?
One revenue line is on record: glean Urodynamics System (Hardware + Testing).
Who are Bright Uro's main competitors?
Direct peers on record are Laborie Medical Technologies and SRS Medical. Broad incumbents are CooperSurgical, Verathon, Medtronic, Boston Scientific, Coloplast and Hollister Incorporated.
Does Bright Uro have an API?
No public API is recorded for Bright Uro.
What industry is Bright Uro in?
Bright Uro's product category is Urodynamics Diagnostic Devices. Its primary akta.pro industry code is HLAHAKAJ, Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status), with a secondary code of HLAKAOAI, Neurourology & Voiding Dysfunction. Its SIC code is 3841.